THX Pharma Société Anonyme (EPA:ALTHX)
3.200
-0.130 (-3.90%)
Oct 22, 2026, 5:35 PM CEST
EPA:ALTHX Revenue
THX Pharma Société Anonyme had revenue of 3.26M EUR in the half year ending June 30, 2026, with 47.10% growth. This brings the company's total for the last twelve months to 3.26M, up 271.60% year-over-year. In the year 2025, THX Pharma Société Anonyme had annual revenue of 806.05K, down -64.70%. That makes THX Pharma Société Anonyme the 40,902nd largest company in the world by revenue and 542nd in France.
Revenue (ttm)
3.26M
Revenue Growth
+271.60%
P/S Ratio
14.29
Revenue / Employee
271.31K
Employees
12
Market Cap
46.54M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 806.05K | -1.48M | -64.70% |
| Dec 31, 2024 | 2.28M | 1.99M | 670.55% |
| Dec 31, 2023 | 296.33K | -118.57K | -28.58% |
| Dec 31, 2022 | 414.90K | 414.30K | 68,819.93% |
| Dec 31, 2021 | 602.00 | -294.01K | -99.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cellectis | 55.86M |
| genOway Société anonyme | 24.58M |
| Nicox | 16.77M |
| Fermentalg | 13.20M |
| Innate Pharma | 9.81M |
| Sensorion | 6.16M |
| ABIONYX Pharma | 4.06M |
| MaaT Pharma | 3.18M |